Wang-Hsin Lee, Ph.D., is a Scientist I in the Department of Pharmacology and Nutritional Sciences at the University of Kentucky College of Medicine. He is trained in nutritional science and molecular metabolism, with research expertise in insulin signaling, liver biology, and metabolic disease. His work focuses on hepatic stellate cells, insulin resistance, fibrosis, obesity, and MASLD, integrating molecular, cellular, and translational approaches.
Dr. Lee earned his Ph.D. in Nutritional Science at the University of Kentucky, where his doctoral research defined cell-type–specific roles of the hepatic insulin receptor and its contribution to liver dysfunction. He employs CRISPR-based gene editing, kinase signaling analysis, transcriptomics, and human metabolic studies to uncover mechanisms driving metabolic and liver diseases.
He has authored and co-authored multiple peer-reviewed publications in journals including Metabolism, Clinical Science, The FASEB Journal, Cell Reports, Antioxidants, and Journal of Biological Chemistry, and has presented his work at national and international conferences. Dr. Lee is an active member of APS and ASBMB and currently serves as a Guest Editor Assistant for an MDPI Livers special issue.
Wang-Hsin Lee, Ph.D., is a Scientist I in the Department of Pharmacology and Nutritional Sciences at the University of Kentucky College of Medicine. He is trained in nutritional science and molecular metabolism, with research expertise in insulin signaling, liver biology, and metabolic disease. His work focuses on hepatic stellate cells, insulin resistance, fibrosis, obesity, and MASLD, integrating molecular, cellular, and translational approaches.
Dr. Lee earned his Ph.D. in Nutritional Science at the University of Kentucky, where his doctoral research defined cell-type–specific roles of the hepatic insulin receptor and its contribution to liver dysfunction. He employs CRISPR-based gene editing, kinase signaling analysis, transcriptomics, and human metabolic studies to uncover mechanisms driving metabolic and liver diseases.
He has authored and co-authored multiple peer-reviewed publications in journals including Metabolism, Clinical Science, The FASEB Journal, Cell Reports, Antioxidants, and Journal of Biological Chemistry, and has presented his work at national and international conferences. Dr. Lee is an active member of APS and ASBMB and currently serves as a Guest Editor Assistant for an MDPI Livers special issue.